|
|
||||||||||||||
|
|
|||||||||||||||
Diagnosis |
Clinical impact ratings Gastroenterology






Key Words: coeliac disease biological markers antibodies
| The first 150 words of the full text of this article appear below. |
METHODS
Data sources:
Medline (1966 to October 2003) and EMBASE/Excerpta Medica (19742003).
Study selection and assessment:
studies that allowed extraction of sensitivity and specificity data and had no fatal methodological flaws. Exclusion criteria: control group did not receive the gold standard (biopsy), biopsy criteria not described, patient disease status for the test under consideration was known, control groups included patients with Marsh I or II biopsy lesions, or AGA tests done without a commercial ELISA kit or before 1990.
Outcomes:
sensitivity and specificity.
MAIN RESULTS
55 studies met the selection criteria. The table
summarises the sensitivity and specificity of each test by patient population.
|
90% and specificities
97% for diagnosis of coeliac disease in children or adults. Antigliadin antibody (IgA class) had sensitivities of 7595% and specificities of 8095%.
Author response
Although we
Neil E Gibson, MD
University of Alberta, St Albert, Alberta, Canada
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |